Please select which sections you would like to print:
verifiedCite
While every effort has been made to follow citation style rules, there may be some discrepancies.
Please refer to the appropriate style manual or other sources if you have any questions.
Using Investopedia, analyze how pharmaceutical companies price drugs.
Explore the con argument from David A. Ricks, the CEO of the drug company Eli Lilly and Company.
Consider how you felt about the issue before reading this article. After reading the pros and cons on this topic, has your thinking changed? If so, how? List two to three ways. If your thoughts have not changed, list two to three ways your better understanding of the other side of the issue now helps you better argue your position.
Push for the position and policies you support by writing U.S. senators and representatives.
Sources
Paul B. Ginsburg and Steven M. Lieberman, “Government Regulated or Negotiated Drug Prices: Key Design Considerations,” brookings.edu, Aug. 30, 2021
“Prescription Drug,” merriam-webster.com (accessed Mar. 29, 2022)
Randa Hilal-Dandan and Laurence L. Brunton, “Appendix I: Principles of Prescription Order Writing and Patient Compliance,” in Goodman and Gilman’s Manual of Pharmacology and Therapeutics, 2nd edition, accesspharmacy.mhmedical.com, 2014
Julia Hawley, “How Pharmaceutical Companies Price Their Drugs,” investopedia.com, Mar. 21, 2022
Melissa Pistilli, “10 Top Pharma Companies by Revenue,” investingnews.com, Dec. 09, 2021
Drug Discovery & Development, “Pharma 50: The 50 Largest Pharmaceutical Companies in the World,” drugdiscoverytrends.com (accessed Mar. 30, 2022)
“Evaluate Pharma World Preview 2020, Outlook to 2026,” evaluate.com, July 16, 2020
American Medical Association, “How Are Prescription Drug Prices Determined?,” ama-assn.org, Apr. 9, 2019
“Pharmacy Benefit Managers and Their Role in Drug Spending,” commonwealthfund.org, Apr. 22, 2019
Sonya Collins, “Most Physicians Unable to Estimate Patients’ Out-of-Pocket Costs: How Pharmacists Can Help,” pharmacytoday.org, Mar. 1, 2022
Rand Corporation, “Prescription Drug Prices in the United States Are 2.56 Times Those in Other Countries,” rand.org, Jan. 28, 2021
Juliette Cubanski, Tricia Neuman, and Meredith Freed, “Explaining the Prescription Drug Provisions in the Build Back Better Act,” kff.org, Nov. 23, 2021
Barbara Sprunt, “House Passes Bill to Cap Insulin Prices,” npr.org, Mar. 31, 2022
Margot Sanger-Katz, “House Passes Bill to Limit Cost of Insulin to $35 a Month,” nytimes.com, Mar. 31, 2022
Kaiser Family Foundation, “Poll: Nearly 1 in 4 Americans Taking Prescription Drugs Say It’s Difficult to Afford Their Medicines, Including Larger Shares Among Those with Health Issues, with Low Incomes and Nearing Medicare Age,” kff.org, Mar. 1, 2019
Paul Brandus, “Opinion: Food or Medication? The Dangerous Choice Many Seniors Have to Make,” marketwatch.com, Mar. 26, 2021
Healio Internal Medicine, “Nearly Half of Americans Forgo Medical Care Because of Cost,” healio.com, Mar. 27, 2018
Truth in Rx, “Price Hikes and Secret Deals,” truthinrx.org (accessed Mar. 29, 2022)
Darrell Hulisz, The Soaring Price of EpiPen,” rn.com (accessed Mar. 31, 2022)
Emily Willingham, “Why Did Mylan Hike EpiPen Prices 400%? Because They Could,” forbes.com, Aug 21, 2016
Cynthia Koons and Robert Langreth, “How Marketing Turned the EpiPen into a Billion-Dollar Business,” bloomberg.com, Sep. 23, 2015
Wayne Drash, “Anatomy of a 97,000% Drug Price Hike: One Family’s Fight to Save Their Son,” cnn.com, June 29, 2018
Heather Long and Matt Egan, “Meet the Guy Behind the $750 AIDS Drug,” money.cnn.com, Sep. 22, 2015
Surescripts, “Data Brief: Physician Perspectives on Access to Patient Data,” surescripts.com, Apr. 2018
Jules Lipoff, “Expensive Prescriptions Have Patients Skipping Their Meds. What Can Doctors Do About It?,” statnews.com, Apr. 3, 2018
Congressional Budget Office, “Research and Development in the Pharmaceutical Industry,” cbo.gov, Apr. 2021
Joe Kennedy, “The Link Between Drug Prices and Research on the Next Generation of Cures,” itif.org, Sep. 9, 2019
“What Are the Average Research and Development Costs for Pharmaceutical Companies?,” investopedia.com, Mar. 11, 2022
David A. Ricks, “The Risks of Government Negotiation of Drug Prices,” bostonglobe.com, Oct. 25, 2021
Jake Ellison, “Drug Rebates for Insurers Tied to Higher Costs for Patients, Especially the Uninsured,” washington.edu, June 15, 2021
Kai Yeung, Stacie B. Dusetzina, and Anirban Basu, “Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007–2018,” jamanetwork.com, June 14, 2021
Cornell Law School Legal Information Institute, “45 CFR § 156.122 - Prescription Drug Benefits,” law.cornell.edu (accessed June 6, 2022)
Chip Davis, “It’s Up to Congress to Make Life-Saving Drugs Affordable,” cnn.com, Feb. 8, 2018
Tom Coburn, “Free Market, Better Medicine,” usnews.com, Feb. 15, 2018
Jake Novack, “Trump’s Losses in Drug Pricing Battle Should Be a Free Market Wake-Up Call to Him,” cnbc.com, July 11, 2019
Jacob James Rich, “It’s Time to Free the Pharmaceutical Market from Government Control,” reason.org, Apr. 3, 2020
Ken Alltucker, “Struggling to Stay Alive: Rising Insulin Prices Cause Diabetics to Go to Extremes,” usatoday.com, Mar. 21, 2019
Kristin Fraser, “Why Americans Are Getting Their Insulin from Mexico,” vice.com, July 21, 2019
Emily Kopp, “Nonprofit Working to Block Drug Imports Has Ties to Pharma Lobby,” npr.org, Mar. 18, 2017
Bram Sable-Smith, “American Travelers Seek Cheaper Prescription Drugs in Mexico and Beyond,” npr.org, Feb. 11, 2019
Public Employees Health Program, “Pharmacy Tourism Program,” pehp.org (accessed Apr. 5, 2022)
Erin Alberty, “Prescriptions from Mexico? Utah Is Paying Public Employees to Make the Trip,” sltrib.com, Jan. 5, 2020
Nisha Kurani, Dustin Cotliar, and Cynthia Cox, “How Do Prescription Drug Costs in the United States Compare to Other Countries?,” healthsystemtracker.org, Feb. 8, 2022
Sydney Lupkin, “FDA Approves Florida’s Plan to Import Cheaper Drugs from Canada,” npr.org, Jan. 5, 2024
The Canadian Press, “Move to Allow Canadian Drugs to Be Imported by U.S. Creates Shortage Fears,” ctvnews.ca, Jan. 5, 2024
“FDA Authorizes Florida’s Drug Importation Program,” fda.gov, Jan. 5, 2024
FDA, “Importation Program Under Section 804 of the FD&C Act,” fda.gov, Jan. 5, 2024
Nisha Kurani, Dustin Cotliar, and Cynthia Cox, “How Do Prescription Drug Costs in the United States Compare to Other Countries?,” healthsystemtracker.org, Feb. 8, 2022
Abbott Laboratories, “Cylert,” American Journal of Diseases of Children, bonkersinstitute.org, 1976
Associated Press, “Drug Maker Pleads Guilty over Lethal Side Effects,” nytimes.com, Dec. 14, 1984
Wei Zhang, et al., “Pharmacogenetics of Drugs Withdrawn from the Market,” Pharmacogenomics, medscape.com, 2012
Michelle R. Carter and Sorour Amirhaeri, “p-ANCA-Associated Vasculitis Caused by Levamisole-Adulterated Cocaine: A Case Report,” Case Reports in Emergency Medicine, hindawi.com, 2013
Marlene Cimons, “Seldane Pulled for a Safer Allergy Drug,” latimes.com, Dec. 30, 1997
Dan Collins, “Insider: FDA Won’t Protect Public,” cbsnews.com, Dec. 7, 2004
Richard DeGrandpre, The Cult of Pharmacology: How America Became the World’s Most Troubled Drug Culture, 2006
“Drugs: The Dangers of Analgesics,” time.com, Feb. 24, 1967
Fairfield State Hospital, “Metrazol Therapy,” fairfieldstatehospital.com, Jan. 15, 2013
“FDA Alerts Consumers of Undeclared Drug Ingredients in Over-the-Counter Diabetes Product,” fda.gov, July 23, 2013
“FDA Announces Voluntary Withdrawal of Pergolide Products: Agency Working with Product Manufacturers,” fda.gov, Mar. 29, 2007
FDA, “FDA Approves First Treatment for Women with Constipation-Predominant Irritable Bowel Syndrome,” web.archive.org, July 24, 2002
“FDA Drug Safety Communication: Voluntary Market Withdrawal of Xigris [Drotrecogin Alfa (Activated)] Due to Failure to Show a Survival Benefit,” fda.gov, Oct. 25, 2011
“FDA Issues Public Health Advisory for Trasylol,” fda.gov, Feb. 8, 2006
“FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg from U.S. Market,” fda.gov, June 21, 2010
“FDA Requests Marketing Suspension of Trasylol,” fda.gov, Nov. 5, 2007
“FDA Requests Removal of All Ranitidine Products (Zantac) from the Market,” fda.gov, Apr. 1, 2020
“FDA Requests the Withdrawal of the Weight-Loss Drug Belviq, Belviq XR (Lorcaserin) from the Market,” fda.gov, Feb. 13, 2020
“How Does FDA Decide When a Drug Is Not Safe Enough to Stay on the Market?,” fda.gov, Jan. 7, 2010
“FDA Statement on the Voluntary Withdrawal of Raptiva from the U.S. Market,” fda.gov, Apr. 8, 2009
“Information for Healthcare Professionals: Pemoline Tablets and Chewable Tablets (Marketed as Cylert),” fda.gov, Oct. 2005
“Information for Healthcare Professionals: Valdecoxib (Marketed as Bextra),” fda.gov, Apr. 7, 2005
“Propulsid (Cisapride) Dear Healthcare Professional Letter Jan 2000,” fda.gov, Jan 24, 2000
“Propoxyphene: Withdrawal—Risk of Cardiac Toxicity,” fda.gov, Nov. 19, 2010
“Public Health Advisory: Suspended Marketing of Palladone (Hydromophone Hydrocloride, Extended-Release Capsules),” fda.gov, July 13, 2005
“Questions and Answers About Withdrawal of Duract,” fda.gov, Aug. 23, 2013
“Questions and Answers about Withdrawal of Fenfluramine (Pondimine) and Dexfenfluramine (Redux),” fda.gov, July, 7, 2005
“Raplon (Rapacuronium Bromide),” fda.gov, Mar. 29, 2001
“Recalling the Omniflox (Temafloxacin) Tablets,” fda.gov, June 5, 1992
“Safety Clinical Trial Shows Possible Increased Risk of Cancer with Weight-Loss Medicine Belviq, Belviq XR (Lorcaserin),” fda.gov, Jan. 14, 2020
“Withdrawal of Product: RAXAR (Grepafloxin HCL) 600 mg Tablets, 400 mg Tablets, and 200 mg Tablets,” fda.gov, Nov. 1, 1999
“Zelnorm (Tegaserod Maleate) Information,” fda.gov, May 11, 2012
Jef Feeley, “Pfizer Ends Rezulin Cases with $205 Million to Spare (Update1),” bloomberg.com, Mar. 31, 2009
Barbara Forney, “Pergolide for Veterinary Use,” wedgewoodpetrx.com (accessed Jan. 6, 2014)
Curt D. Furgerg and Bertram Pitt, “Withdrawal of Cerivastatin from the World Market,” ncbi.nlm.nih.gov, Sep. 26, 2001
Raymond Goldberg, Drugs Across the Spectrum, 6th edition, 2010
Barbara Hammes and Cynthia Laitman, “Pharmaceutical Company Advertisement for DES by the Grant Chemical Company, Brooklyn, NY, Printed in the ‘American Journal of Obstetrics & Gynecology’ in 1957,” Journal of Midwifery and Women’s Health, medscape.com, 2003
David Healy, Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression, 2004
Charles D. Helper and Richard Segal, Preventing Medication Errors and Improving Drug Therapy Outcomes: A Management Systems Approach, 2003
Irritable Bowel Syndrome Self Help and Support Group, “Lotronex,” ibsgroups.org (accessed Jan. 6, 2014)
Harvey Kirk, “Darvon and Darvocet Deaths Lead FDA Panel to Recommend Recall,” youhavealawyer.com, Feb. 2, 2009
“Lilly Announces Withdrawal of Xigris R Following Recent Clinical Trial Results,” fda.gov, Oct. 25, 2011
National Cancer Institute, “Diethylstilbestrol (DES) and Cancer,” cancer.gov, Oct. 5, 2011
Steven Morris, “Abbott Gets FDA Approval for Omniflox Antibiotic,” chicagotribune.com, Feb. 1, 1992
MSNBC, “Report: Vioxx Linked to Thousands of Deaths,” nbcnews.com, Oct. 6, 2004
Pink Sheet, “FDA Clears Treatment IND for Colon Cancer Drug Levamisole,” elsevierbi.com, May 15, 1989
Res Obscura, “From Quacks to Quaaludes: Three Centuries of Drug Advertising,” resobscura.blogspot.nl, June 11, 2012
“Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves,” reuters.com, Oct. 21, 2019
Renato M.E. Sabbatini, “The History of Shock Therapy in Psychiatry,” crerbromente.org.br (accessed Dec. 19, 2013)
Christian Sinclair, “Are You Glad Darvocet Got Pulled by the FDA? Are You Sure?,” pallimed.org, Nov. 30, 2010
Ruth SoRelle, “Withdrawal of Posicor from Market,” circ.ahajournals.org, 1998
Sheryl Gay Stolberg, “New Painkiller Is Withdrawn After 4 Deaths,” nytimes.com, June 23, 1998
Bernadette Tansey, “Hard Sell: How Marketing Drives the Pharmaceutical Industry/The Side Effects of Drug Promotion/Aggressive Ads for Painkillers Left More Patients Exposed to Risk,” sfgate.com, Feb. 27, 2005
